FindTrial
Sign In

Multi-center, prospective study evaluating real-world effectiveness of systemic treatments with Atopic Dermatitis Control Tool (ADCT ©) in patients with moderate to severe atopic dermatitis in South Korea

Multi-center, prospective study evaluating real-world effectiveness of systemic treatments with Atopic Dermatitis Control Tool (ADCT ©) in patients with moderate to severe atopic dermatitis in South Korea

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006578
Enrollment
112
Registered
2021-09-14
Start date
2021-10-01
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Incheon St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 13 years of age

Exclusion criteria

Exclusion criteria: Patients under 12 years of age

Design outcomes

Primary

MeasureTime frame
% of patients achieving ADCT score <7—

Secondary

MeasureTime frame
% of patients achieving EASI50 and EASI 75—

Countries

Korea, Republic of

Contacts

Public ContactSangHyun Cho

The Catholic University of Korea, Incheon St. Mary's Hospital

drchos@yahoo.co.kr+82-32-280-5101

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026